Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Non-invasive Aesthetic Treatment Market, by End-use
1.4.2 Europe Non-invasive Aesthetic Treatment Market, by Procedure
1.4.3 Europe Non-invasive Aesthetic Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Product Launches and Product Expansions
3.2.2 Acquisition and Mergers
3.2.3 Partnerships, Collaborations and Agreements
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Sep – 2022, Feb) Leading Players
Chapter 4. Europe Non-invasive Aesthetic Treatment Market by End-use
4.1 Europe MedSpa Market by Country
4.2 Europe Hospital/Surgery Center Market by Country
4.3 Europe Traditional Spa Market by Country
4.4 Europe HCP Owned Clinic Market by Country
Chapter 5. Europe Non-invasive Aesthetic Treatment Market by Procedure
5.1 Europe Injectables Market by Country
5.2 Europe Skin Rejuvenation Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Non-invasive Aesthetic Treatment Market by Country
6.1 Germany Non-invasive Aesthetic Treatment Market
6.1.1 Germany Non-invasive Aesthetic Treatment Market by End-use
6.1.2 Germany Non-invasive Aesthetic Treatment Market by Procedure
6.2 UK Non-invasive Aesthetic Treatment Market
6.2.1 UK Non-invasive Aesthetic Treatment Market by End-use
6.2.2 UK Non-invasive Aesthetic Treatment Market by Procedure
6.3 France Non-invasive Aesthetic Treatment Market
6.3.1 France Non-invasive Aesthetic Treatment Market by End-use
6.3.2 France Non-invasive Aesthetic Treatment Market by Procedure
6.4 Russia Non-invasive Aesthetic Treatment Market
6.4.1 Russia Non-invasive Aesthetic Treatment Market by End-use
6.4.2 Russia Non-invasive Aesthetic Treatment Market by Procedure
6.5 Spain Non-invasive Aesthetic Treatment Market
6.5.1 Spain Non-invasive Aesthetic Treatment Market by End-use
6.5.2 Spain Non-invasive Aesthetic Treatment Market by Procedure
6.6 Italy Non-invasive Aesthetic Treatment Market
6.6.1 Italy Non-invasive Aesthetic Treatment Market by End-use
6.6.2 Italy Non-invasive Aesthetic Treatment Market by Procedure
6.7 Rest of Europe Non-invasive Aesthetic Treatment Market
6.7.1 Rest of Europe Non-invasive Aesthetic Treatment Market by End-use
6.7.2 Rest of Europe Non-invasive Aesthetic Treatment Market by Procedure
Chapter 7. Company Profiles
7.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Agreements:
7.1.5.3 Acquisitions and Mergers:
7.1.5.4 Partnerships, Collaborations and Agreements:
7.2 Allergan PLC (AbbVie)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Approvals and Trials:
7.3 Galderma S.A.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations and Agreements:
7.4 Merz Pharma GmbH & Co. KGaA
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental &Regional Analysis
7.5.4 Research & Development Expenses
7.6 Candela Medical Corporation
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisitions and Mergers:
7.6.2.2 Partnerships, Collaborations and Agreements:
7.7 Bausch Health Companies, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Cutera, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.9 Lumenis Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product Launches and Product Expansions:
7.10. Hologic, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisitions and Mergers:
7.10.5.2 Product Launches and Product Expansions:
Unique Offerings 